Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	50.83	37.79	38.52	54.84
Short-Term Investments	197.5	109.75	-	27.77
Cash & Short-Term Investments	248.33	147.54	38.52	82.61
Cash Growth	80.64%	283.01%	-53.37%	-
Prepaid Expenses	4	3.46	0.69	1.22
Total Current Assets	252.33	150.99	39.21	83.83
Property, Plant & Equipment	9.31	10.3	11.62	1.79
Long-Term Investments	76.67	20.51	-	-
Other Long-Term Assets	0.96	3.96	1.12	1.74
Total Assets	339.27	185.75	51.95	87.37
Accounts Payable	1.48	1.19	0.72	0.56
Accrued Expenses	6.93	7.67	6.59	7.7
Current Portion of Leases	1.22	1.07	0.73	-
Other Current Liabilities	0.22	0.49	-	-
Total Current Liabilities	9.85	10.42	8.04	8.25
Long-Term Leases	7.75	8.68	9.75	-
Total Liabilities	17.6	19.1	17.79	8.25
Common Stock	0.04	0.01	0	0
Additional Paid-In Capital	557.12	17	4.52	2.23
Retained Earnings	-235.91	-181.09	-119.4	-72.14
Comprehensive Income & Other	0.42	0.37	-	-0.02
Total Common Equity	321.67	-163.71	-114.88	-69.92
Shareholders' Equity	321.67	166.66	34.16	79.12
Total Liabilities & Equity	339.27	185.75	51.95	87.37
Total Debt	8.97	9.75	10.48	-
Net Cash (Debt)	316.03	158.29	28.04	82.61
Net Cash Growth	84.95%	464.45%	-66.05%	-
Net Cash Per Share	10.55	41.02	9.56	32.05
Filing Date Shares Outstanding	44.63	44.12	3.05	2.58
Total Common Shares Outstanding	44.46	4.72	3.05	2.58
Working Capital	242.48	140.57	31.17	75.58
Book Value Per Share	7.23	-34.66	-37.66	-27.13
Tangible Book Value	321.67	-163.71	-114.88	-69.92
Tangible Book Value Per Share	7.23	-34.66	-37.66	-27.13
Machinery	2.2	2.18	2.05	0.62
Construction In Progress	-	-	-	1.52
Leasehold Improvements	1.91	1.85	1.85	-

Source: S&P Capital IQ. Standard template. Financial Sources.